adverse effects of tirzepatide Side Cancer: Evidence and Safety Data 20 Possible Tirzepatide Side Effects

The GIP receptor activation is approximately five times stronger than the GLP-1 activation, which creates a pharmacological profile distinct from pure GLP-1 agonists like semaglutide

Cardiovascular Issues: Changes in metabolic functions may increase the risk of hypertension and heart disease

Weight Management : Under the brand name Wegovy, semaglutide is approved for weight loss in people with obesity or those who are overweight and have weight-related health conditions such as high blood pressure or high cholesterol

A stomach hernia occurs when there is a weakness in the abdominal wall or muscle, allowing a small portion of the stomach to protrude